Channeling effects in the prescription of new therapies: the case of emicizumab for hemophilia A - Supplementary materials.xlsx
dataset
posted on 2022-05-10, 09:59 authored by Arash Mahajerin, Imi Faghmous, Peter Kuebler, Monet Howard, Tao XU, Carlos Flores, Tiffany Chang, Francis NissenChanneling effects in the prescription of new therapies - the case of emicizumab for hemophilia A: Supporting information
Supplementary Table 1: Code listings
